Author

@SpacBobby SpacBobby

High-conviction, transparent space-sector perma-bull who synthesizes the ASTS/RKLB/SpaceX thesis

Posts real-time long calls, dip-buying disclosures, position

trader score
-6.05
hit rate
10%
mean α
-2.98%
signals 14d
136

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 10% hit rate, -2.98% mean alpha, trader score -6.05. Their last-14d mentions, direction-adjusted, have moved -16.5% since posting (mean over 101 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-16ASTS@SpacBobby+0.45Expresses optimism about ASTS and the forthcoming J-LEO development.-2.1%
2026-10-16ASTS@SpacBobby+0.40Blue Origin capacity and Bluebird launch capacity are presented as constructive for ASTS deployment.-2.1%
2026-10-16RKLB@SpacBobby-0.40Citizens cuts RKLB's target to $90 from $130 while retaining Market Outperform after a launch delay.+3.5%
2026-10-16RKLB@SpacBobby+0.40Needham reiterates a Buy rating and $120 target on Rocket Lab.+3.5%
2026-10-15TSLA@SpacBobby+0.45Reacting positively to a Tesla Roadster flight demonstration.+2.7%
2026-10-15·@SpacBobby·Predicts a rally in rate-sensitive stocks if the 10-year yield falls below 5%.·
2026-10-15SPCX@SpacBobby+0.00Clear Street cuts RKLB launch, revenue and EBITDA forecasts but remains positive on long-term demand and IRDM synergies.·
2026-10-15RKLB@SpacBobby-0.25Clear Street cuts RKLB launch, revenue and EBITDA forecasts but remains positive on long-term demand and IRDM synergies.-4.8%
2026-10-15IRDM@SpacBobby+0.15Clear Street cuts RKLB launch, revenue and EBITDA forecasts but remains positive on long-term demand and IRDM synergies.-1.3%
2026-10-15·@SpacBobby·DCA and buy owned companies whose fundamentals are unchanged. — Explicitly says to dollar-cost average and buy amid price and sentiment weakness.·
2026-10-15ASTS@SpacBobby+0.70Discloses buying AST SpaceMobile shares below $40.-10.5%
2026-10-15·@SpacBobby·Says markets will react negatively to a 63% probability of a December rate hike.·
2026-10-15RKLB@SpacBobby+0.25Cantor reiterates Overweight and a $122 target despite moving its Neutron launch estimates into 2027.-4.8%
2026-10-15RKLB@SpacBobby-0.40Clear Street cuts Rocket Lab's target to $105 from $129 while retaining Buy.-4.8%
2026-10-15RKLB@SpacBobby+0.35Roth Capital keeps Buy and a $110 target despite Rocket Lab's launch delay.-4.8%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.